G. Nadolski

Hospital of the University of Pennsylvania — United States

Medicine · Health Sciences

32h-index3.6kcitations287works0.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatocellular Carcinoma Treatment and Prognosis(59), Lymphatic Disorders and Treatments(54), Vascular Malformations and Hemangiomas(27), Liver Disease and Transplantation(24), Liver Disease Diagnosis and Treatment(22)

Publications287 total

Persistent Lymphatic Ascites After Liver Transplantation: Identification of the Underlying Mechanism of Ascites Permits Successful Percutaneous Treatment
CardioVascular and Interventional Radiology·2026Open Access
Factors affecting the difficulty of transurethral double J stent removal in patients with renal transplants
Diagnostic and Interventional Radiology·2025Open Access
Tunneled dialysis catheter placement in intensive care unit patients: influence of catheter tip design on clinical performance
CVIR Endovascular·2025Open Access
Clinical and molecular dissection of CAR T cell resistance in pancreatic cancer
Cell Reports Medicine·2025· 2 citedOpen Access
Transjugular intrahepatic portosystemic shunt creation using intravascular ultrasound <i>vs</i> fluoroscopic guidance: A dual-institution retrospective comparative study
World Journal of Hepatology·2025· 1 citedOpen Access
Abstract 6852: Targeted administration of lactate dehydrogenase inhibitor during transarterial of hepatocellular cardinomas in a rat model
Cancer Research·2025
Management of Ascites: <i>AJR</i> Expert Panel Narrative Review
American Journal of Roentgenology·2025
Lipiodol deposition in NET liver metastases during TACE using pressure-enabled versus endhole catheters: pilot data from a randomized, internally-controlled trial
Endocrine Abstracts·2025
Can NK1 antagonists and COX-2 inhibitors improve same-day discharge rates following chemoembolization?
Endocrine Abstracts·2025
Abstract No. 237 Pilot Randomized Trial of Transarterial Chemoembolization with or without Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma in Patients Awaiting Transplantation
Journal of Vascular and Interventional Radiology·2025
Abstract No. 238 Premedication with NK-1 Antagonists and COX-2 Inhibitors Improves Same-Day Discharge Rates Following Chemoembolization for Hepatocellular Carcinoma and Neuroendocrine Liver Metastasis
Journal of Vascular and Interventional Radiology·2025Open Access
Abstract No. 583 Drain for Life? Outcomes of Percutaneous Drainage of Malignancy-Associated Abscesses
Journal of Vascular and Interventional Radiology·2025
Abstract No. 249 ▪ FEATURED ABSTRACT The Effects of a Standardized Enhanced Recovery After Surgery (ERAS) Pain Management Protocol for Patients Undergoing a Uterine Fibroid Embolization (UFE)
Journal of Vascular and Interventional Radiology·2025Open Access
Abstract No. 219 A Single Institutional Experience with Pulsed Electric Field Ablation in the Treatment of Patients with Localized and Metastatic Cancer
Journal of Vascular and Interventional Radiology·2025
Abstract No. 572 Utility of Alpha-Fetoprotein (AFP) Monitoring After Y-90 Radioembolization of Hepatocellular Carcinoma in Non-AFP Producers
Journal of Vascular and Interventional Radiology·2025
Lymphatic Embolization for Primary Genital Lymphorrhea and Chylous Reflux–Related Lower Limb Lymphedema
Journal of Vascular and Interventional Radiology·2025· 1 cited
Intranodal Glue Embolization Compared to Surgical Fenestration for Management of Post-Kidney Transplant Lymphoceles
American Journal of Transplantation·2025Open Access
Comparison of Liquid with Particle Embolics in a Translational Rat Model of Hepatocellular Carcinoma: Histologic and Radiographic Responses
Journal of Vascular and Interventional Radiology·2024
Outcomes of Intranodal and Modified Intranodal Lymphangiography for Treatment of Traumatic Chylous Leaks in the Thorax and Neck
CardioVascular and Interventional Radiology·2024Open Access
Supplementary Figure S2 from Integrated Imaging Probe and Bispecific Antibody Development Enables &lt;i&gt;In Vivo&lt;/i&gt; Targeting of Glypican-3–Expressing Hepatocellular Carcinoma
2024Open Access
page 1 of 15Next →

Frequent Co-authors

Maxim Itkin(19), Michael C. Soulen(15), Stephen J. Hunt(12), T. Gade(11), S. William Stavropoulos(10), Scott O. Trerotola(7), Yoav Dori(5), Emma E. Furth(5), Richard D. Shlansky-Goldberg(5), Jeffrey I. Mondschein(4), Timothy W.I. Clark(4), Ryan M. Kiefer(4), Deepak Sudheendra(4), Saebeom Hur(3), Alexey Gurevich(3), Charles N. Weber(3), Stephen Pickup(3), Erin Pinto(2), Marcus Buggert(2), Michael R. Betts(2)